Alisa W. Serio
Alisa W. Serio publishes mostly in Molecular Medicine, Molecular Biology and Epidemiology, on topics such as Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Mycobacterium research and diagnosis.
- World rank
- #2,339,260 of 7,710,434 ranked researchers
- Rank in United States
- #696,344 of 1,627,098
- Works
- 64
- Citations
- 2.8k
- Citations per work
- 43.5
What does Alisa W. Serio research?
Alisa W. Serio's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (29%), Immunology and Microbiology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences2335.4%
- Everything else2335.4%
- Health Sciences1929.2%
- Medicine1929.2%
- 1Molecular Medicine17% of their works
- 2Molecular Biology13% of their works
- 3Epidemiology12% of their works
- 4Infectious Diseases9% of their works
- 5Pharmacology9% of their works
- 6Applied Microbiology and Biotechnology5% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Antibiotics Pharmacokinetics and Efficacy
- Mycobacterium research and diagnosis
- Tuberculosis Research and Epidemiology
- Antibiotic Use and Resistance
- Bacterial Identification and Susceptibility Testing
- Bacterial Genetics and Biotechnology
- RNA and protein synthesis mechanisms
Which keywords describe Alisa W. Serio's research?
The keywords of their largest research topics: Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Epidemiology, Diagnosis, Treatment, Drug Resistance and Antibiotic Pharmacokinetics.
- Ribosome
- Bacterial Physiology
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Antimicrobial Stewardship
- Mycobacterium tuberculosis
- Mycobacterium avium
- Antibiotic Pharmacokinetics
- Treatment
- Epidemiology
- ESKAPE Pathogens
- Antibiotic Resistance
- Multidrug-Resistant Bacteria
- Diagnosis
- Drug Resistance
- Critically Ill Patients
- Nontuberculous Mycobacteria
- Tuberculosis
- Global Health
- Microorganism Identification
- Gene Regulation
- Translation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antibiotic Resistance564 topics
- ESKAPE Pathogens311 topic
- Multidrug-Resistant Bacteria311 topic
- Epidemiology303 topics
- Diagnosis212 topics
- Treatment212 topics
- Drug Resistance192 topics
- Antibiotic Pharmacokinetics161 topic
- Critically Ill Patients161 topic
- Mycobacterium avium111 topic
- Nontuberculous Mycobacteria111 topic
- Mycobacterium tuberculosis101 topic
- Tuberculosis101 topic
- Antimicrobial Stewardship91 topic
- Global Health91 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry71 topic
- Microorganism Identification71 topic
- Bacterial Physiology51 topic
- Gene Regulation51 topic
- Ribosome51 topic
- Translation51 topic
Where does Alisa W. Serio work?
Alisa W. Serio's main affiliation in the publication record is Paratek Pharmaceuticals (United States), United States.
How many publications and citations does Alisa W. Serio have?
OpenAlex counts 64 works and 2,784 citations for Alisa W. Serio, an h-index of 24, ranking #2,339,260 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Alisa W. Serio. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.